AVEO Pharmaceuticals, Inc.
AVEO
AVEO was delisted on the 19th of January, 2023.
82 hedge funds and large institutions have $78.5M invested in AVEO Pharmaceuticals, Inc. in 2013 Q2 according to their latest regulatory filings, with 82 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
70% less call options, than puts
Call options by funds: $194K | Put options by funds: $644K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
76
Tower Research Capital (TRC)
New York
| $10K | +$17.1K | +400 | New |
|
77
Ameriprise
Minneapolis,
Minnesota
| $9K | +$15.9K | +373 | New |
|
78
Teacher Retirement System of Texas
Austin,
Texas
| $8K | +$13.2K | +309 | New |
|
79
Wells Fargo
San Francisco,
California
| $2K | +$3.42K | +80 | New |
|
|
RFC
80
Russell Frank Company
Seattle,
Washington
| $1K | +$1.07K | +25 | New |
|
|
U
81
UBS
Zurich,
Switzerland
| $1K | +$2.14K | +50 | New |
|
82
BlackRock
New York
| – | +$855 | +20 | New |
|
AVEO Hedge Fund Activity: Q2 2013 in Review
82 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q2 2013, worth a combined $78.5M.
Buyers outnumbered sellers: 82 funds opened new AVEO positions and 0 closed out — a net gain of 82 holders — while 0 added to existing stakes and 0 trimmed.
- 82 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $78.5M of AVEO Pharmaceuticals, Inc. stock for Q2 2013.
- 82 funds opened new AVEO Pharmaceuticals, Inc. positions in Q2 2013 and 0 closed out, a net change of +82 holders.
Based on aggregated 13F filings for Q2 2013.